Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
motexafin gadolinium | thioredoxin reductase | NA | Successful target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Lymphoma[MeSHID:D008223] Malignant neoplasm of lung[MeSHID:D008175] Malignant neoplasm of brain[MeSHID:D001932] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] HIV Infections[MeSHID:D015658] |
NA | approved | unknown |
motexafin gadolinium | ribonucleoside-diphosphate reductase subunit m2 | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Lymphoma[MeSHID:D008223] Malignant neoplasm of lung[MeSHID:D008175] Malignant neoplasm of brain[MeSHID:D001932] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] HIV Infections[MeSHID:D015658] |
NA | investigational | unknown |
motexafin gadolinium | thioredoxin reductase 1, cytoplasmic | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Lymphoma[MeSHID:D008223] Malignant neoplasm of lung[MeSHID:D008175] Malignant neoplasm of brain[MeSHID:D001932] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] HIV Infections[MeSHID:D015658] |
NA | investigational | unknown |
motexafin gadolinium | thioredoxin reductase 2, mitochondrial | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Lymphoma[MeSHID:D008223] Malignant neoplasm of lung[MeSHID:D008175] Malignant neoplasm of brain[MeSHID:D001932] Lymphoma Non-Hodgkin[MeSHID:D008228] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] HIV Infections[MeSHID:D015658] |
NA | investigational | unknown |
click here to return to the previous page |